ANFOE 10000IU INJECTION

Anfoe 10000IU Injection contains erythropoietin, a prescription medicine used to manage anemia in patients with chronic kidney disease (CKD), chemotherapy-induced anemia, and certain surgical conditions. By stimulating red blood cell production in the bone marrow, Anfoe helps improve hemoglobin levels and oxygen delivery in the body.

Anfoe works as a targeted therapy for anemia, enhancing the body’s ability to produce healthy red blood cells. This mechanism supports better energy levels, reduces fatigue, and improves overall quality of life in patients suffering from anemia due to chronic illness or medical treatments.

Administered via subcutaneous or intravenous injection under strict medical supervision, Anfoe 10000 IU Injection ensures safe and effective management of anemia. This product is commonly used in hospitals and clinical settings and is prescribed by healthcare professionals according to patient-specific needs.

Product Features

• Effective anti-anemia injectable therapy
• Contains Erythropoietin 10,000 IU
• Stimulates red blood cell production
• Used in CKD and chemotherapy-related anemia
• Suitable for hospital and dialysis center use
• Administered via subcutaneous or intravenous route
• Manufactured under GMP-compliant standards
• Prescription-required injectable medicine

How It Helps

• Stimulates bone marrow to produce healthy red blood cells
• Improves hemoglobin levels and oxygen delivery
• Reduces fatigue and anemia-related symptoms
• Supports effective management of CKD and chemotherapy-induced anemia